Announcements Trials

Browse Landscape

Phase

Phase NA 8 Phase 2 2 Phase 1/2 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3 Specimen Handling 2 Papillomavirus Vaccines 2 Lenalidomide 2 Immune Checkpoint Inhibitors 2 Imatinib Mesylate 2 Human Papillomavirus Recombinant Vaccine nonavalent 2 Diosmin 2 Dexamethasone 2 venetoclax 1 trametinib 1 tocilizumab 1 sofosbuvir-velpatasvir drug combination 1 semaglutide 1 ruxolitinib 1 rozanolixizumab 1 rasburicase 1 radium Ra 223 dichloride 1 pyrotinib 1 pirtobrutinib 1 oxycodone-acetaminophen 1 obinutuzumab 1 nirogacestat 1 nilotinib 1 ixazomib 1 idelalisib 1 human papillomavirus vaccine, L1 type 16, 18 1 fluciclovine F-18 1 darolutamide 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Blood Specimen Collection × 30 days × Clear all

NCT06274515 2026-05-06

REMERGE

Hoffmann-La Roche

Phase 4 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡